Nike’s North American results should begin to accelerate again as the sportswear maker pushes back against competitors.
The cloud software company’s expansion appetite is giving Salesforce’s investors indigestion.
An oil producers’ meeting in Algeria may be surprisingly productive but there will be little fundamental impact of a freeze on a still-glutted market.
Nestlé SA on Monday announced a reshuffling of its executive board, as the food and beverage giant preps for new leadership at the beginning of next year.
U.S. employers struggling to find enough qualified industrial workers are turning to Germany for a solution to plug the U.S. skills gap: vocational training.
Audi said head of technical development Stefan Knirsch resigned from the company’s board effective immediately.
Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.
Weighing Tesla’s merger offer for SolarCity means separating what can and can’t be measured.
Pfizer said it would remain a single company, deciding not to split into one business focused on patent-protected drugs and another on cash-rich older products.
Whether Donald Trump or Hillary Clinton wins in November, they will enjoy far less latitude to spend money or cut taxes than any president since World War II.